A new treatment for preterm pre-eclampsia could benefit mother and child
Authors:
- 11 May 2026
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 32 (6) , 1977-1978
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialNature Medicine, 2026
- Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology, 2025
- Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: Bridging epidemiological knowledge into personalized postpartum care and follow-upPregnancy Hypertension, 2024
- Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathwaysAmerican Journal of Obstetrics and Gynecology, 2022
- Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trialBMJ, 2021
- Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in PreeclampsiaCirculation, 2011
- Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsiaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005